TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks September 1, 1989
TCL Archive Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia May 25, 2007